open access

Vol 27, No 2 (2020)
Original articles — Basic science and experimental cardiology
Submitted: 2018-12-26
Accepted: 2019-05-04
Published online: 2019-05-13
Get Citation

Transient receptor potential channel TRPV4 mediates TGF-β1-induced differentiation of human ventricular fibroblasts

Min-Soo Ahn1, Young Woo Eom2, Ji-Eun Oh2, Seung-Kuy Cha3, Kyu Sang Park3, Jung-Woo Son1, Jun-Won Lee1, Young Jin Youn1, Sung Gyun Ahn1, Jang-Young Kim1, Seung-Hwan Lee1, Junghan Yoon1, Byung-Su Yoo1
DOI: 10.5603/CJ.a2019.0050
·
Pubmed: 32329036
·
Cardiol J 2020;27(2):162-170.
Affiliations
  1. Cardiology Division, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic Of
  2. Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic Of
  3. Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic Of

open access

Vol 27, No 2 (2020)
Original articles — Basic science and experimental cardiology
Submitted: 2018-12-26
Accepted: 2019-05-04
Published online: 2019-05-13

Abstract

Background: Cardiac fibroblasts (CFs) are principal extracellular matrix-producing cells. In response to injury, CFs transdifferentiate into myofibroblasts. Intracellular calcium (Ca2+) signaling, involved in fibroblast proliferation and differentiation, is activated in fibroblasts through transient receptor potential (TRP) channels, but the function of these channels has not been investigated in human ventricular CFs. Under evaluation in this study, was the role of TRP channels in the differentiation of human ventricular CFs induced by transforming the growth factor beta (TGF-β), a pro-fibrotic cytokine.

Methods: Human ventricular CFs were used in this study. The differentiation of CFs into myofibroblast was induced with TGF-β and was identified by the expression of smooth muscle actin.

Results: Results indicate that Ca2+ signaling was an essential component of ventricular CF dif­ferentiation. CFs treated with TGF-β demonstrated increased expression of a TRP channel, TRPV4, both at the mRNA and protein levels, which corresponded with CF-myofibroblast trans-differentiation, as evidenced by the upregulation of α-smooth muscle actin, a myofibroblast marker, and plasminogen activator inhibitor-1, which are fibrogenesis markers. An agonist of TRPV4 induced the conversion of CFs into myofibroblasts, whereas it’s antagonist as well a Ca2+ chelating agent reduced it, indicating that the Ca2+ influx throughTRPV4 is required for CF trans-differentiation. Overall, these results dem­onstrate that TRPV4-mediated Ca2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway.

Conclusions: Overall, these results demonstrate that TRPV4-mediated Ca2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway.

Abstract

Background: Cardiac fibroblasts (CFs) are principal extracellular matrix-producing cells. In response to injury, CFs transdifferentiate into myofibroblasts. Intracellular calcium (Ca2+) signaling, involved in fibroblast proliferation and differentiation, is activated in fibroblasts through transient receptor potential (TRP) channels, but the function of these channels has not been investigated in human ventricular CFs. Under evaluation in this study, was the role of TRP channels in the differentiation of human ventricular CFs induced by transforming the growth factor beta (TGF-β), a pro-fibrotic cytokine.

Methods: Human ventricular CFs were used in this study. The differentiation of CFs into myofibroblast was induced with TGF-β and was identified by the expression of smooth muscle actin.

Results: Results indicate that Ca2+ signaling was an essential component of ventricular CF dif­ferentiation. CFs treated with TGF-β demonstrated increased expression of a TRP channel, TRPV4, both at the mRNA and protein levels, which corresponded with CF-myofibroblast trans-differentiation, as evidenced by the upregulation of α-smooth muscle actin, a myofibroblast marker, and plasminogen activator inhibitor-1, which are fibrogenesis markers. An agonist of TRPV4 induced the conversion of CFs into myofibroblasts, whereas it’s antagonist as well a Ca2+ chelating agent reduced it, indicating that the Ca2+ influx throughTRPV4 is required for CF trans-differentiation. Overall, these results dem­onstrate that TRPV4-mediated Ca2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway.

Conclusions: Overall, these results demonstrate that TRPV4-mediated Ca2+ influx participates in regulating the differentiation of human ventricular CFs into myofibroblasts through the MAPK/ERK pathway.

Get Citation

Keywords

fibroblast, myofibroblast, transient receptor potential channels, calcium

About this article
Title

Transient receptor potential channel TRPV4 mediates TGF-β1-induced differentiation of human ventricular fibroblasts

Journal

Cardiology Journal

Issue

Vol 27, No 2 (2020)

Pages

162-170

Published online

2019-05-13

Page views

1589

Article views/downloads

1111

DOI

10.5603/CJ.a2019.0050

Pubmed

32329036

Bibliographic record

Cardiol J 2020;27(2):162-170.

Keywords

fibroblast
myofibroblast
transient receptor potential channels
calcium

Authors

Min-Soo Ahn
Young Woo Eom
Ji-Eun Oh
Seung-Kuy Cha
Kyu Sang Park
Jung-Woo Son
Jun-Won Lee
Young Jin Youn
Sung Gyun Ahn
Jang-Young Kim
Seung-Hwan Lee
Junghan Yoon
Byung-Su Yoo

References (24)
  1. Jourdan-Lesaux C, Zhang J, Lindsey ML. Extracellular matrix roles during cardiac repair. Life Sci. 2010; 87(13-14): 391–400.
  2. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999; 79(1): 215–262.
  3. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res. 2000; 46(2): 250–256.
  4. Flack EC, Lindsey ML, Squires CE, et al. Alterations in cultured myocardial fibroblast function following the development of left ventricular failure. J Mol Cell Cardiol. 2006; 40(4): 474–483.
  5. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2011; 51(4): 600–606.
  6. Petrov VV, Fagard RH, Lijnen PJ. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension. 2002; 39(2): 258–263.
  7. Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3(5): 349–363.
  8. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003; 4(7): 517–529.
  9. Kamkin A, Kiseleva I, Wagner KD, et al. A possible role for atrial fibroblasts in postinfarction bradycardia. Am J Physiol Heart Circ Physiol. 2002; 282(3): H842–H849.
  10. Kohl P, Noble D. Mechanosensitive connective tissue: potential influence on heart rhythm. Cardiovasc Res. 1996; 32(1): 62–68.
  11. Nilius B. TRP channels in disease. Biochim Biophys Acta. 2007; 1772(8): 805–812.
  12. Adapala RK, Thoppil RJ, Luther DJ, et al. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J Mol Cell Cardiol. 2013; 54: 45–52.
  13. Davis J, Burr AR, Davis GF, et al. A TRPC6-dependent pathway for myofibroblast transdifferentiation and wound healing in vivo. Dev Cell. 2012; 23(4): 705–715.
  14. Du J, Xie J, Zhang Z, et al. TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation. Circ Res. 2010; 106(5): 992–1003.
  15. Harada M, Luo X, Qi XY, et al. Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation. 2012; 126(17): 2051–2064.
  16. Thodeti CK, Paruchuri S, Meszaros JG. A TRP to cardiac fibroblast differentiation. Channels (Austin). 2013; 7(3): 211–214.
  17. Wei ZL, Nguyen MT, O'Mahony DJR, et al. Identification of orally-bioavailable antagonists of the TRPV4 ion-channel. Bioorg Med Chem Lett. 2015; 25(18): 4011–4015.
  18. Marshall ICB, Boyfield I, McNulty S. Ratiometric Ca2+ measurements using the FlexStation scanning fluorometer. Methods Mol Biol. 2006; 312: 119–124.
  19. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol. 2012; 227(2): 493–507.
  20. Kumaran C, Shivakumar K. Calcium- and superoxide anion-mediated mitogenic action of substance P on cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2002; 282(5): H1855–H1862.
  21. Ramires FJ, Sun Y, Weber KT. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade. J Mol Cell Cardiol. 1998; 30(3): 475–483.
  22. Kamkin A, Kiseleva I, Wagner KD, et al. Mechanically induced potentials in fibroblasts from human right atrium. Exp Physiol. 1999; 84(2): 347–356.
  23. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002; 415(6868): 198–205.
  24. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium. 2005; 38(3-4): 233–252.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl